3 best performing ASX shares in the week of 1 August 2022

Marc Kennis Marc Kennis, August 8, 2022

Best performing ASX shares

The three best performing ASX shares in the week of 1 August 2022 were Plexure Group (ASX:PX1), up 97.1%, Resapp Health (ASX:RAP), up 65.2%, and Paradigm Biopharmaceuticals (ASX:PAR), up 52.2%.

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

1. Plexure Group (ASX:PX1)

Industry: Software & IT Services

Plexure Group Limited (ASX:PX1) is a global mobile engagement company helping brands create sticky and more profitable relationships with consumers. Harnessing the power of consumer, contextual, behavioral and sales data, we enable the delivery of deeply personalized compelling offers to customers through mobile channels.

Market Cap: $118m

12 month high / low: $0.125 – $0.73

 

Plexure

 

 

2. Resapp Health (ASX:RAP)

Industry: Technology

ResApp Health Limited (ASX:RAP) is a digital health company developing smartphone applications for the diagnosis and management of respiratory disease. The technology is based on machine learning algorithms that use cough sounds to diagnose and measure the severity of respiratory conditions without the need for additional hardware.

Market Cap: $163M

12 month high / low: $0.042 – $0.1975

 

ResApp

 

 

3. Paradigm Biopharmaceuticals (ASX:PAR)

Industry: Healthcare

Paradigm Biopharmaceuticals Limited (ASX:PAR) wraps our 3 best performing ASX shares this week. PAR is involved in researching and developing therapeutic products for human use. It is a drug repurposing company, which seeks to find new uses for old drugs, thereby reducing the cost and time to bring therapeutics to market. 

Market Cap: $392m

12 month high / low: $0.855 – $2.69

 

Paradigm Biopharmaceuticals

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get the Latest Insider Trades on ASX!

Recent Posts

These 2 ASX Healthcare Stocks Are Quietly Cashing In on the AI Revolution

ASX Healthcare Stocks Benefiting From AI Artificial intelligence is reshaping healthcare faster than most investors realise. Hospital imaging systems, pathology…

Which ASX Uranium Stocks Benefit Most From the Iran War and the Hormuz Oil Crisis?

ASX Uranium Stocks to Watch This Week Brent crude is sitting just above US$111 a barrel as of this morning,…

Telix pharmaceuticals (ASX: TLX) A$230m Quarter Puts Guidance Back In Play

Is Telix in Turnaround Mode or Dead-Cat Bounce? The question investors are now asking about Telix pharmaceuticals is whether the…